Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SMS Pharmaceuticals Limited
SMSPHARMA | NSE
346.20
INR-0.10
-0.03%
SMSPHARMA | NSE
About SMS Pharmaceuticals Limited
Sector
Healthcare
Industry
Drug Manufacturers-General
Earnings date
31/03/2024
As of date
11/10/2024
Close
346.20
Open
348.50
High
349.40
Low
340.00
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers anti-ulcer anti-fungal anti-migraine anti-diabetic erectile dysfunction antiemetic antiepileptic antipsychotic anti-hypertensive anti-anginal anti-viral urinary antispasmodic and anti-retroviral APIs. It is also involved in the contract research activities. The company also exports its products. SMS Pharmaceuticals Limited was incorporated in 1987 and is based in Hyderabad India.
View LessSMSPHARMA | NSE
Risk
54.5
Sharpe
3.18
Luna's Score
52/100
Recommendation
Hold
Luna says (SMSPHARMA | NSE)
What's Working
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
56.0%1 month
54.5%3 months
60.6%6 months
54.7%Returns
Fundamental Ratios
PE
54.02
Fwd. PE
-
Price to book
5.90
Debt to equity
0.52
Debt to assets
0.27
Ent. to EBITDA
28.32
Ent. to rev.
4.82
PEG
-
Other Fundamentals
EBITDA
1.23B
MarketCap
30.06B
MarketCap(USD)
357.45M
Div. yield
0.11
Op. margin
15.28
Erngs. growth
77.30
Rev. growth
21.50
Ret. on equity
10.00
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
60.80
Range1M
67.95
Range3M
165.39
Volumes: Market Activity
Rel. volume
0.27
Price X volume
54.05M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 28.32 | 26.58 | Par |
| Ent. to Revenue | 4.82 | 6.75 | Cheaper |
| PE Ratio | 54.02 | 43.49 | Expensive |
| Price to Book | 5.90 | 10.73 | Cheaper |
| Dividend Yield | 0.11 | 0.95 | Poor |
| Std. Deviation (3M) | 60.62 | 41.58 | Riskier |
| Debt to Equity | 0.52 | 0.14 | Expensive |
| Debt to Assets | 0.27 | 0.08 | Expensive |
| Market Cap | 30.06B | 191.03B | Emerging |
